Allergic rhinitis, asthma, and atherosclerosis in the Bruneck and ARMY studies.
暂无分享,去创建一个
W. Poewe | S. Kiechl | A. Mayr | J. Willeit | M. Knoflach | G. Wick
[1] U. Thorsteinsdóttir,et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. , 2005, American journal of human genetics.
[2] Carlos Iribarren,et al. Are patients with asthma at increased risk of coronary heart disease? , 2004, International journal of epidemiology.
[3] A. Lusis,et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. , 2004, The New England journal of medicine.
[4] Qingbo Xu,et al. Autoimmune and inflammatory mechanisms in atherosclerosis. , 2004, Annual review of immunology.
[5] J. Gulcher,et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke , 2004, Nature Genetics.
[6] G. Stingl,et al. Underestimation of allergies in elderly patients , 2004, The Lancet.
[7] A. Togias. Systemic effects of local allergic disease. , 2004, The Journal of allergy and clinical immunology.
[8] I. McInnes,et al. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. , 2003, Circulation.
[9] Duanping Liao,et al. Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. , 2003, American journal of epidemiology.
[10] Ruurd van der Zee,et al. Cardiovascular Risk Factors and Atherosclerosis in Young Males: ARMY Study (Atherosclerosis Risk-Factors in Male Youngsters) , 2003, Circulation.
[11] J. Bousquet,et al. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma) , 2003, Allergy.
[12] Qingbo Xu,et al. Active and Passive Smoking, Chronic Infections, and the Risk of Carotid Atherosclerosis: Prospective Results From the Bruneck Study , 2002, Stroke.
[13] A. Lusis,et al. Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in Mice , 2002, Circulation research.
[14] P. Demoly,et al. ERASM, a pharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France , 2002, Allergy.
[15] Werner Poewe,et al. Chronic Infections and the Risk of Carotid Atherosclerosis: Prospective Results From a Large Population Study , 2001, Circulation.
[16] Bert Brunekreef,et al. Relation between airborne pollen concentrations and daily cardiovascular and respiratory-disease mortality , 2000, The Lancet.
[17] S. Kiechl,et al. Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[18] D. Postma,et al. Eosinophilia and positive skin tests predict cardiovascular mortality in a general population sample followed for 30 years. , 1999, American journal of epidemiology.
[19] S. Kiechl,et al. The natural course of atherosclerosis. Part I: incidence and progression. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[20] B. Metzler,et al. The role of mast cells in atherosclerosis. , 1997, International archives of allergy and immunology.
[21] R. Langer,et al. IgE predicts future nonfatal myocardial infarction in men. , 1996, Journal of clinical epidemiology.
[22] P. Enright,et al. Asthma and its association with cardiovascular disease in the elderly. The Cardiovascular Health Study Research Group. , 1996, The Journal of asthma : official journal of the Association for the Care of Asthma.
[23] S. Kiechl,et al. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[24] Qingbo Xu,et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis , 1993, The Lancet.
[25] E. Karaagaoglu,et al. Levels of IgE in the serum of patients with coronary arterial disease. , 1991, International journal of cardiology.
[26] D. Cook,et al. Short stature, lung function and risk of a heart attack. , 1989, International journal of epidemiology.
[27] S. Coughlin,et al. IgE and cardiovascular disease. Results from a population-based study. , 1987, The American journal of medicine.
[28] H. Wedel,et al. Peak expiratory flow and risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. , 1986, American journal of epidemiology.